McIlrath & Eck’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

McIlrath & Eck’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-30	Closed	-$1.29K	–	1010
2024 Q4	$1.29K	Buy	+30	New	+$1.36K	﹤0.01%	892

Other funds holding XPH

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

KWM

Kingsview Wealth Management Grants Pass, Oregon $7.33B AUM 16.07% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

FCBT

First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Envestnet Portfolio Solutions Chicago, Illinois $18.1B AUM 15% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

McIlrath & Eck's XPH Position: Q1 2025 in Review

McIlrath & Eck sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q1 2025, closing a stake of 30 shares — an estimated $1.29K sold.

McIlrath & Eck first reported a position in XPH in Q4 2024 and held it in 1 quarter. The position peaked at $1.29K in Q4 2024. 70 funds tracked by Wall St. Rank hold XPH as of Q1 2025.

McIlrath & Eck reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q1 2025 after selling out during the quarter.
McIlrath & Eck sold 30 State Street SPDR S&P Pharmaceuticals ETF shares in Q1 2025, an estimated $1.29K.
McIlrath & Eck first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q4 2024 and held it in 1 quarter.
McIlrath & Eck's State Street SPDR S&P Pharmaceuticals ETF position peaked at $1.29K in Q4 2024.
70 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q1 2025.

Based on McIlrath & Eck's 13F filing for Q1 2025, filed 16 May 2025.